Contact Us
  Search
The Business Research Company Logo
Ingestible Biosensors Market Report 2026
Published :July 2026
Pages :250
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Ingestible Biosensors Market Report 2026

Global Outlook – By Product Type (Capsule Biosensors, Pill Biosensors, Other Product Types), By Sensor Type (Temperature Sensors, pH Sensors, Image Sensors, Other Sensor Types), By Application (Medical Diagnostics, Drug Delivery, Patient Monitoring, Other Applications), By End-User (Hospitals And Clinics, Research Institutes, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030

Ingestible Biosensors Market Overview

• Ingestible Biosensors market size has reached to $1.97 billion in 2025 • Expected to grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 10.3% • Growth Driver: Surge In Awareness Of Real-time Monitoring Fueling The Growth Of The Market Due To Rising Focus On Proactive Healthcare Management • Market Trend: Technological Advancement in Ingestible Vitals-Monitoring Capsules • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ingestible Biosensors Market?

Ingestible biosensors are advanced medical devices designed to be safely swallowed and travel through the gastrointestinal tract, where they continuously monitor physiological parameters such as pH, temperature, pressure, or specific biomarkers. These sensors transmit real-time data to external devices, enabling physicians to assess digestive health, detect abnormalities, and optimize personalized treatment plans, while reducing the need for invasive procedures. The main components of ingestible biosensors are capsule biosensors, pill biosensors, and others. Ingestible biosensors, or capsule biosensors, are swallowable devices equipped with sensors that monitor physiological or biochemical parameters inside the gastrointestinal tract and transmit the data for diagnostic or therapeutic purposes. The various sensor types include temperature sensors, pH sensors, image sensors, and others. It is used for several applications, including medical diagnostics, drug delivery, patient monitoring, sports and fitness, and others, and serves end-users, including hospitals and clinics, research institutes, home care, and others.
Ingestible Biosensors Market Bar Graph

What Is The Ingestible Biosensors Market Size and Share 2026?

The ingestible biosensors market size has grown rapidly in recent years. It will grow from $1.97 billion in 2025 to $2.18 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to limitations of traditional endoscopy, demand for non invasive diagnostics, advances in miniaturized sensors, rising gastrointestinal disorders, early capsule endoscopy adoption.

What Is The Ingestible Biosensors Market Growth Forecast?

The ingestible biosensors market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to growth in personalized medicine, integration with mobile health platforms, expanding elderly population, technological improvements in data transmission, increased clinical adoption. Major trends in the forecast period include non invasive gastrointestinal monitoring, smart capsule based diagnostics, real time internal health tracking, personalized digestive health analysis, minimally invasive diagnostic alternatives.
Research Expert

Book your 30 minutes free consultation with our research experts

Top Market Segments Chart For Ingestible Biosensors Market Showing Segment-Wise Market Share Distribution.

Global Ingestible Biosensors Market Segmentation

1) By Product Type: Capsule Biosensors, Pill Biosensors, Other Product Types 2) By Sensor Type: Temperature Sensors, pH Sensors, Image Sensors, Other Sensor Types 3) By Application: Medical Diagnostics, Drug Delivery, Patient Monitoring, Other Applications 4) By End-User: Hospitals And Clinics, Research Institutes, Other End Users Subsegments: 1) By Capsule Biosensors: Single Sensor Capsule, Multi Sensor Capsule, Smart Capsule 2) By Pill Biosensors: Diagnostic Pill, Therapeutic Pill, Monitoring Pill 3) By Other Product Types: Patch Integrated Capsule, Biodegradable Sensor, Wearable Assisted Sensor

What Is The Driver Of The Ingestible Biosensors Market?

The increasing awareness of real-time monitoring is expected to propel the growth of the ingestible biosensors market going forward. Real-time monitoring refers to the continuous process of collecting, analyzing, and transmitting data as it is generated, allowing for immediate health assessment and timely medical intervention. Increasing awareness of real-time monitoring is rising due to the growing emphasis on proactive healthcare management, as patients and providers recognize its role in enabling early detection of health issues and timely medical interventions. Ingestible biosensors enable real-time monitoring by transmitting physiological data from within the body, allowing continuous tracking of parameters such as medication adherence, gastrointestinal activity, and biomarker levels for timely diagnosis and personalized treatment. For instance, in October 2024, according to a report published by HealthArc, a US-based healthcare solutions provider, around 30 million patients in the U.S. were utilizing remote patient monitoring (RPM), with the number anticipated to rise to 70.6 million by the end of 2025. Additionally, 42 states have included RPM under Medicaid coverage, and more than 26% of Americans are expected to adopt it. Therefore, the increasing awareness of real-time monitoring is driving the growth of the ingestible biosensors industry.

Key Players In The Global Ingestible Biosensors Market

Major companies operating in the ingestible biosensors market are Otsuka Holdings Co. Ltd., Proteus Digital Health Inc., etectRx Inc., CapsoVision Inc., IntroMedic Co. Ltd., BodyCap S.A.S., AnX Robotica Corporation, Atmo Biosciences Pty Ltd., Check-Cap Ltd., Chongqing Jinshan Science & Technology Group Co. Ltd., RF Co. Ltd., Biora Therapeutics Inc., EnteraSense Ltd., Lucid Medical Diagnostics Pvt. Ltd., Medisafe Capsule Technologies Ltd., Medtronic plc, Verily Life Sciences LLC, Olympus Corporation, JIFU Medical Technology Co. Ltd., Smart Medical Systems Ltd.
Top 10 Competitor Analysis And Market Overview Pie Chart For The Ingestible Biosensors Market

This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.

Bubble Chart Of Company Scoring Matrix By Innovation, Brand And Revenue For The Ingestible Biosensors Market

This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.

Explore how leading companies compare across key metrics in our report Get Report

What Are Latest Mergers And Acquisitions In The Ingestible Biosensors Market?

In May 2025, imec VZW, a Belgium-based non-profit research and technology organization, partnered with OnePlanet Research Center to advance sustainable technology solutions by leveraging its expertise in nanoelectronics and digital innovations in partnership with OnePlanet Research Center, focusing on developing impactful and environmentally responsible research outcomes. OnePlanet Research Center is a Netherlands-based multidisciplinary innovation and research institute focusing on developing advanced healthcare solutions, including ingestible biosensors that enable real-time monitoring of vital signs and gastrointestinal health.
Market Analysis Map Highlighting Largest Region For Ingestible Biosensors Market

Regional Outlook

North America was the largest region in the ingestible biosensors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
Need data for a specific geography? Request Regional Data

What Defines the Ingestible Biosensors Market?

The ingestible biosensors market consists of sales of ingestible sensor devices, including capsule-based sensors, electronic pills, and smart drug delivery systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Market Attractiveness Scoring And Analysis Chart Evaluating Growth, Competition, Risk Factors For The Ingestible Biosensors Market

This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.

Total Addressable Market Analysis Chart Displaying Revenue Potential And Market Size For The Ingestible Biosensors Market

This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.

Access full TAM calculations and growth projections in our report Get Report

What Key Data and Analysis Are Included in the Ingestible Biosensors Market Report 2026?

The ingestible biosensors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ingestible biosensors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Ingestible Biosensors Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$2.18 billion
Revenue Forecast In 2030$3.23 billion
Growth RateCAGR of 10.3% from 2026 to 2030
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2030
Segments CoveredProduct Type, Sensor Type, Application, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Key Companies ProfiledOtsuka Holdings Co. Ltd., Proteus Digital Health Inc., etectRx Inc., CapsoVision Inc., IntroMedic Co. Ltd., BodyCap S.A.S., AnX Robotica Corporation, Atmo Biosciences Pty Ltd., Check-Cap Ltd., Chongqing Jinshan Science & Technology Group Co. Ltd., RF Co. Ltd., Biora Therapeutics Inc., EnteraSense Ltd., Lucid Medical Diagnostics Pvt. Ltd., Medisafe Capsule Technologies Ltd., Medtronic plc, Verily Life Sciences LLC, Olympus Corporation, JIFU Medical Technology Co. Ltd., Smart Medical Systems Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us